title: Managing the menopause: British Menopause Society Council consensus statement on hormone replacement therapy.
abstract: The British Menopause Society Council aims to help health professionals inform and advise women about the menopause. This guidance regarding estrogen-based hormone replacement therapy (HRT), including tibolone, which is classified in the British National Formulary as HRT, responds to the results and analysis of the randomized Women's Health Initiative studies and the observational Million Women Study. Treatment choice should be based on up-to-date information and targeted to individual women's needs. HRT still offers the potential for benefit to outweigh harm, providing the appropriate regimen has been instigated in terms of dose, route and combination.
authors.affiliation: The British Menopause Society, 4-6 Eton Place, Marlow, Buckinghamshire SL7 2QA, UK.
authors.forename: Joan
authors.initials: J
authors.lastname: Pitkin
authors.forename: Margaret C P
authors.initials: MC
authors.lastname: Rees
authors.forename: Sarah
authors.initials: S
authors.lastname: Gray
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Lumsden
authors.forename: Jo
authors.initials: J
authors.lastname: Marsden
authors.forename: John
authors.initials: J
authors.lastname: Stevenson
authors.forename: Jennifer
authors.initials: J
authors.lastname: Williamson
mesh_terms: D015914:Estrogen Replacement Therapy / Q000009:adverse effects / Q000379:methods; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008593:Menopause / Q000187:drug effects; D013222:State Medicine; D006113:United Kingdom; D016387:Women's Health